Gapping down
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- MTB -2.5%, INMD -1.5%
Other news:
- EXAS -3% (JAMA Oncology publication strengthens evidence for Oncotype DX test reliability across racial and ethnic groups)
- GCL -1% (discloses departure and appointment of certain officers)
- PFE -0.5% (reports update on oral GLP-1 receptor agonist Danuglipron)